Bone Biologics Corp. (BBLG) vs Iterum Therapeutics PLC (ITRMF)

Bone Biologics Corp. and Iterum Therapeutics PLC are both Biotechnology companies. Iterum Therapeutics PLC is the larger, with a market value of $1.6M against $1.4M — 1.2× the size. Bone Biologics Corp. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 12 metrics below, Bone Biologics Corp. leads on 7 and Iterum Therapeutics PLC on 5.

Valuation

Metric BBLG ITRMF Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.22 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 24.37 10.73
Earnings yield (285.42%) 0.00% (28.84%)
Free cash flow yield (304.81%) 0.00% (23.03%)

Profitability

Metric BBLG ITRMF Biotechnology median
Gross margin — (81.85%) 65.16%
Operating margin 0.00% (2,243.48%) 0.00%
Net margin 0.00% (2,930.54%) 0.00%
Free cash flow margin 0.00% (2,122.61%) 0.00%
Return on equity (54.96%) 285.48% (57.72%)
Return on assets (50.55%) (111.35%) (49.22%)
Return on invested capital 0.00% (455.51%) 0.00%

Growth

Metric BBLG ITRMF Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 90.85% 57.43% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG ITRMF Biotechnology median
Debt to equity 0.00 (2.87) 0.00
Current ratio 8.67 2.13 4.73
Net debt to EBITDA 1.65 0.24 0.96

Dividend

Metric BBLG ITRMF Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BBLG ITRMF Biotechnology median
Market cap 1.35m 1.59m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack